23andMe Files for Chapter 11 Bankruptcy Amid Disruptions 23andMe, the genetics testing company, has entered Chapter 11 bankruptcy proceedings in the United States as of Sunday. This move comes in light of a significant fall in the company’s market value and declining demand for its products, largely influenced by a substantial data breach that occurred in 2023. Bankruptcy Proceedings and …
